Goldman Sachs’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Goldman Sachs’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-375,000	Closed	-$1.18M	–	7678
2015 Q2	$1.18M	Sell	375,000 -601,900	-62%	-$2.06M	﹤0.01%	4389
2015 Q1	$2.79M	Buy	976,900 +157,200	+19%	+$402K	﹤0.01%	3464
2014 Q4	$2.12M	Buy	+819,700	New	+$3.59M	﹤0.01%	3783
2013 Q3	–	Sell	-40,000	Closed	-$469K	–	6816
2013 Q2	$469K	Buy	+40,000	New	+$400K	﹤0.01%	4993

Goldman Sachs's SZYM Position: Q2 2016 in Review

Goldman Sachs sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 794,380 shares — an estimated $1.61M sold.

Goldman Sachs first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $3.72M in Q3 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Goldman Sachs reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Goldman Sachs sold 794,380 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $1.61M.
Goldman Sachs first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
Goldman Sachs's SOLAZYME INC COM STK (DE) position peaked at $3.72M in Q3 2013.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.